JP2024525805A - 眼の疾患および障害における視機能を改善するための方法および組成物 - Google Patents

眼の疾患および障害における視機能を改善するための方法および組成物 Download PDF

Info

Publication number
JP2024525805A
JP2024525805A JP2024502082A JP2024502082A JP2024525805A JP 2024525805 A JP2024525805 A JP 2024525805A JP 2024502082 A JP2024502082 A JP 2024502082A JP 2024502082 A JP2024502082 A JP 2024502082A JP 2024525805 A JP2024525805 A JP 2024525805A
Authority
JP
Japan
Prior art keywords
peptide
composition
eye
pharma
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024502082A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024525805A5 (https=
Inventor
ジェー． コカブ，アンドルー
アイ． チャン，コンスタンス
エヌ． ザックス，デイヴィッド
エー． エスポージト，デイヴィッド
デ ゴアー，ジャナ ヴァン
クラインマン，デイヴィッド
エム． ゴジー，リンジー
マリク，スシャンタ
Original Assignee
オーエヌエル セラピューティクス，インク．
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by オーエヌエル セラピューティクス，インク． filed Critical オーエヌエル セラピューティクス，インク．
Publication of JP2024525805A publication Critical patent/JP2024525805A/ja
Publication of JP2024525805A5 publication Critical patent/JP2024525805A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/179—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
JP2024502082A 2021-07-13 2022-07-12 眼の疾患および障害における視機能を改善するための方法および組成物 Pending JP2024525805A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163221329P 2021-07-13 2021-07-13
US63/221,329 2021-07-13
US202263336896P 2022-04-29 2022-04-29
US63/336,896 2022-04-29
PCT/US2022/036830 WO2023287794A2 (en) 2021-07-13 2022-07-12 Methods and compositions for improving visual function in ocular diseases and disorders

Publications (2)

Publication Number Publication Date
JP2024525805A true JP2024525805A (ja) 2024-07-12
JP2024525805A5 JP2024525805A5 (https=) 2025-07-17

Family

ID=84919637

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024502082A Pending JP2024525805A (ja) 2021-07-13 2022-07-12 眼の疾患および障害における視機能を改善するための方法および組成物

Country Status (5)

Country Link
US (2) US20240299488A1 (https=)
EP (1) EP4370208A4 (https=)
JP (1) JP2024525805A (https=)
AU (1) AU2022311780A1 (https=)
WO (1) WO2023287794A2 (https=)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010102052A2 (en) * 2009-03-03 2010-09-10 The Regents Of The University Of Michigan Methods of inhibiting photoreceptor apoptosis
US10508134B2 (en) * 2015-05-01 2019-12-17 Onl Therapeutics, Inc. Peptide compositions and methods of use

Also Published As

Publication number Publication date
US20240299488A1 (en) 2024-09-12
WO2023287794A2 (en) 2023-01-19
EP4370208A2 (en) 2024-05-22
US20240197815A1 (en) 2024-06-20
WO2023287794A3 (en) 2023-04-06
AU2022311780A1 (en) 2024-02-08
EP4370208A4 (en) 2025-05-14

Similar Documents

Publication Publication Date Title
JP7725540B2 (ja) 眼の感染症および疾患を処置するための組成物および方法
CA2806942C (en) Compounds for the treatment/prevention of ocular inflammatory diseases
JP2025541151A (ja) 眼の疾患および障害における視機能を改善するための方法および組成物
US20040213782A1 (en) Compositions of an aquaporin modulating agent and an aqueous humor modulating agent for the treatment of elevated intraocular pressure
US20240156898A1 (en) Methods and compositions for treating ocular disorders and diseases
JP2024525805A (ja) 眼の疾患および障害における視機能を改善するための方法および組成物
CN113453686A (zh) 治疗眼表痛的方法
CN117957010A (zh) 改善眼部疾病和病症中视功能的方法和组合物
JP2025541152A (ja) 眼病変を処置するための方法および組成物
US20250360123A1 (en) Methods and compositions for treating inherited retinal degeneration
WO2025184235A1 (en) Methods and compositions for treating glaucoma
WO2024220669A1 (en) Methods and compositions for treating rnfl thinning
KR20230131213A (ko) 탄파너셉트 안과용 조성물을 이용한 안구건조증의 치료
Rajendra Prakash Maurya et al. Recent advances in thyroid eye disease: An overview
WO2014115011A1 (en) Compositions for use in treating eye disorders using opioid receptor antagonists

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240202

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250709

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250709